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AVERTING THE CLONE AGE: PROSPECTS
AND PERILS OF HUMAN DEVELOPMENTAL
MANIPULATION
Stuart A. Newman*
INTRODUCTION
New biotechnologies developed over the past three decades,
together with changes in the public discourse around reproductive and
reparative medicine, have led to an accelerated deconstruction of the
notion of the human. Whereas biological, anthropological,
philosophical and sociolegal definitions of human identity before this
period were hardly consonant with each other, they were all
constrained and unified by the inherent grounding of human identity
and individuality in human biology. Members of the human species
have a common, and coherent, evolutionary history and therefore a
shared genome, which up to now has been subject to random shuffling,
but not purposeful replication or manipulation.! The uniqueness of
human individuals is also due in part to genetics, specifically genetic
variation. Correspondingly, the legacy of all persons having resulted
from a genetic "roll of the dice," and being therefore biologically
unprecedented, has also contributed to the shared human condition.
Finally, while there have been ambiguities and disagreements over
whether certain naturally-occurring human organisms, such as embryos
or the "brain-dead," are part of the human community, it has
previously not been possible to fabricate quasi-human entities for
particular uses.
This is all changing. The capacity afforded by biotechnology to
manipulate the human embryo at its early stages, including its genetic
material (DNA), has placed the notion of a common humanity up for
grabs. Modification of the early embryo, referred to in what follows
as "developmental" modification or manipulation, is unlike
* A.B. Columbia College, 1965; Ph.D. (Chemistry) University of Chicago, 1970;
Professor of Cell Biology and Anatomy, New York Medical College, 1984-present.
1. See RICHARD LEWONTIN, HUMAN DIVERSITY, (Scientific American Books
1982), and L. LUCA CAVALLI-SFORZA et al., THE HISTORY AND GEOGRAPHY OF
HUMAN GENES (Princeton University Press 1994).
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manipulations of the fully formed individual, including provision of
artificial limbs, heart valve and joint replacements, cosmetic surgery,
and even "somatic" (differentiated body cell) gene therapy.
Developmental modification changes the generative trajectory of the
individual and turns it into something intrinsically different from what
it would have become without the manipulation With these
procedures there is no guarantee that even the original species-
character will be maintained.3  Although one objective in applying
such methods to our own species may be to fabricate improved
humans, in some cases, by accident or by intent, the outcomes will be
quasi-human or less than human.
Apprehensions concerning such prospects were raised by a number
of speculative writers of acute technological and social foresight at the
dawn of the Industrial Revolution.4 Hints of these concerns can be
found even earlier.' In our own period, these prospects have been the
subject both of warnings6 and enthusiasm.' This paper will outline the
2. See Stuart A. Newman, The Hazards of Human Developmental Gene
Modification, 13 GENE WATCH 10, (2000). The earlier during development a
change is made, the more thoroughgoing is the alteration of the organism. Very
early developmental manipulations, such as those involved with cloning and
germline modification, inevitably alter the development of the brain.
3. For biological aspects of species identity and alteration see Stuart A.
Newman, Carnal Boundaries: The Commingling of Flesh in Theory and Practice in
LYNDA BURKE AND RUTH HUBBARD, REINVENTING BIOLOGY: RESPECT FOR LIFE
AND THE CREATION OF KNOWLEDGE 191-227 (Indiana University Press 1995). For
legal aspects see George L. Annas et al., Protecting the Endangered Human:
Toward an International Treaty Prohibiting Cloning and Inheritable Alterations, 28
AM. J. LAW MED. 145,151 (2002).
4. See Mary Wollstonecraft Shelley, Frankenstein (Modern Library 1984);
H.G. Wells, The Island of Doctor Moreau (William Heinemann 1896); Aldous
Huxley, Brave New World (Doubleday 1932).
5. See CHAYIM BLOCH, THE GOLEM (John Vennay 1925) which describes the
medieval Jewish legend of a fabricated man.
6. See Lori B. Andrews, The Clone Age: Adventures in the New World of
Reproductive Technology (Henry Holt & Co. 1999). See also Francis Fukuyama,
Our Posthuman Future: Consequences of the Biotechnology Revolution (Farrar
Straus & Giroux 2003) and Bill McKibben, Enough: Staying Human in an
Engineered Age (Henry Holt & Co. 2003).
7. See Lee M. Silver, Remaking Eden: Cloning and Beyond in a Brave New
World (Avon Books 1997); Allen Buchanan et al., From Chance to Choice:
Genetics and Justice (Cambridge University Press 2002); and Gregory Stock,
Redesigning Humans: Our Inevitable Genetic Future (Houghton Mifflin 2002).
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scientific background to these new capabilities and provide a realistic
assessment of how quickly we are approaching the "clone age."' In
addition, it will consider what measures may be taken to avert its most
negative aspects. To this end, changes in the relevant science over the
last thirty years will be reviewed, both in its technological
achievements and in the socioeconomic dimensions of its conduct. The
paper will conclude with specific recommendations on how ill-
considered manipulation of human biology may be prevented.
II. RAMPING UP TO THE CLONE AGE: TECHNOLOGICAL
ASPECTS
Beginning in the late 1970s, the field of human reproductive
medicine began to utilize methods of in vitro fertilization (IVF) and
embryo implantation that up until then had been the exclusive
province of animal breeders. 9 The success of these techniques in
livestock production were grounded in mid 20 'h century scientific
progress in endocrinology and reproductive physiology. However,
calls, and eventually demands, for their use in management of human
fertility coincided with wider acceptance of women's autonomy
consequent on the women's liberation movement of the late 1960s and
1970s, and with economic realities that both demanded women's
participation in the job market and created incentives for the
rationalization of family planning.'°
As they were being introduced, scientifically informed concerns
were voiced that such procedures could induce developmental
abnormalities and therefore constituted unwarranted experimentation
8. See ANDREWS, supra note 6. Like Andrews, I use "clone age" to describe
societal changes produced by implementation of new and anticipated reproductive
technologies including, but not restricted to, cloning.
9. NEW YORK ACADEMY OF SCIENCES, IN VITRO FERTILIZATION AND OTHER
ASSISTED REPRODUCTION (Howard W. Jones, Jr. and Charlotte Schrader, eds.,
New York Academy of Sciences 1988). This volume is a collection of papers on the
scientific basis of human assisted reproduction, but the interplay with studies on
farm animal reproductive science and dependence of the human applications on
earlier studies on non-human species is evident throughout.
10. See ANDREWS, supra note 6. Legal landmarks in the acquisition of
reproductive autonomy by women during this period were the Supreme Court
decisions in Griswold v. Connecticut, 381 U.S. 479 (1965) which affirmed the right
to use and be counseled in the use of contraceptives, and in Roe v. Wade, 410 U.S.
113 (1973) which affirmed the right to abortion.
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on individuals intended to be brought to term." There were also
concerns about the implications of separating the production of
humans from the traditional nexus of social relations 2 In addition,
more practical considerations inevitably arose about the assignment of
medical liability if, and when, this manipulation led to adverse
outcomes.
13
Despite these concerns, the growing market for these procedures,
mainly among people in affluent nations, ensured the quick expansion
of fertility services. For many hopeful parents, obtaining "genetically
related" children,14 regardless of what would previously have been
insurmountable biological obstacles, came to be considered a right."5
Louise Brown, the first "test tube baby," arrived without evident
problems in 1977, and thousands of children whose existence is
dependent on IVF are now born each year.16  Society has largely
accommodated itself to the burdens of the technology, although all the
original concerns have proved valid to one extent or another."
11. Leon R. Kass, Babies By Means of In Vitro Fertilization: Unethical
Experiments on the Unborn?, 285 N. ENGL. J. MED. 1174, 1175 (1971).
12. Martin M. Quigley & Lori B. Andrews, Human In Vitro Fertilization and
the Law, 42 FERTIL. & STERIL. 348 (1984).
13. See, e.g., Mark E. Cohen, The "Brave New Baby" and the Law:
Fashioning Remedies for the Victims of In Vitro Fertilization, 4 AM. J. L. & MED.
319, 328-336 (1978); Dennis M. Flannery et al., Test Tube Babies: Legal Issues
Raised by In Vitro Fertilization, 67 GEO. L. J. 1295, 1333 (1979); G. Craig Hubble,
Liability of the Physician for the Defects of a Child Caused by In Vitro
Fertilization, 2 J. LEG. MED. 501, 509-521 (1981).
14. See generally B. S. Shastry, SNP Alleles in Human Disease and Evolution,
47 J. HUM. GENET. 561 (2002). In any two randomly selected human genomes,
99.9% of the DNA sequence is identical, so everyone is "genetically related." A
parent and child have half their gene variants in common, making them slightly
more similar than two randomly chosen individuals. To many, this distinction
clearly makes a big difference, but it is useful to consider it in perspective.
15. See Suzanne Uniacke, In Vitro Fertilization and the Right to Reproduce, 1
BIOETHIcs 241, 241 (1987); see also ANDREWS, supra note 6.
16. Patricia Katz et al., The Economic Impact of the Assisted Reproductive
Technologies, 4 SUPPL. NAT. CELL BIOL. S29, S29 (2002).
17. On adverse developmental outcomes, see Robert M. Winston & Kate
Hardy, Are We Ignoring Potential Dangers of In Vitro Fertilization and Related
Treatments? 4 SUPPL. NAT. CELL BIOL. S14, S14 (2002); on legal questions see
Goran Samsioe & Anders Abreg, Ethical Issues in Obstetrics, 41 INT. J. FERT.
MENOPAUSAL STUD. 284, 284-285 (1996); on familial and psychological problems,
(Footnote continued...)
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Whatever social barriers previously stood in the way of using IVF
for humans, they gave way precisely at the time modern molecular
genetics began to take off. The paper that established the possibility of
recombining, amplifying, and propagating isolated segments of DNA
was published in 1973. By 1977, methods had been found to
determine the sequence of subunits in DNA molecules, 9 a step that
was indispensable to realizing the potential of the recombinant DNA
techniques. For human reproductive biology, this translated into the
determination of the sequence aberrations in such genetically related
conditions as cystic fibrosis and Duchenne muscular dystrophy,20 and
to the possibility of using this information for preimplantation genetic
diagnosis. The claimed right to have a genetically related child now
evolved into the right to have such a child free from potentially
disabling genetic variants carried by the biological parents.
In the case of animal embryology, a branch of the now burgeoning
field of developmental biology, the application of the new methods
had dramatic consequences. By 1982, "transgenic" mice, which
utilized the information in, and transmitted to their offspring, foreign
genes that had been introduced at early embryonic stages, had been
produced.2' This opened the way for proposals to enable people to
have genetically related offspring who not only were free of the "bad"
gene variants carried by the parents, but who also could have gene
variants not carried by either parent.2
see Alexina McWhinnie, Families From Assisted Conceptions: Ethical and
Psychological Issues, 3 HuM. FERTIL. 13, 13 (2000).
18. S.N. Chang, et al., Construction of Biologically Functional Bacterial
Plasmids In Vitro, 70 PROC. NATL. ACAD. Sci. U.S.A. 3240 (1973).
19. Allan M. Maxam & Walter Gilbert, A New Method for Sequencing DNA,
74 PROC. NATL. AcAD. Sci. U.S.A. 560, 560 (1977); F. Sanger et al., DNA
Sequencing with Chain Terminating Inhibitors, 74 PROC. NATL. ACAD. Sci. U.S.A.
5463, 5463 (1977).
20. Donald B. Bloch, et al., The Gene for the Alpha il Subunit of Human
Guanine Nucleotide Binding Protein Maps Near the Cystic Fibrosis Locus, 42 AM.
J. HUM. GENET. 884, 884 (1988). See also A.P. Monaco & L. M. Kunkel, Cloning
of the Duchenne/Becker Muscular Dystrophy Locus, 17 ADV. HUM. GENET. 61
(1988).
21. Richard D. Palmiter, et al., Dramatic Growth of Mice that Develop From
Eggs Microinjected with Metallothionian-Growth Hormone Fusion Genes,
NATURE, Dec. 2, 1982, at 611.
22. See Ruth Hubbard & Stuart Newman, Yuppie Eugenics, Z MAGAZINE,
March 2002, at 36.
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The field of developmental biology generated a series of additional
findings beginning in the 1970s that initially had only distant
connections to any prospect for manipulation of human biology, but
which have ultimately proved key to the deconstructive program.
Most of these findings depended not so much on advances in DNA
technology, but rather on general technical progress in other aspects of
embryology and cell biology.
One of these was a demonstration in 1997 (after much preparatory
work with amphibians, dating back to the 1950s) that mammals could
be genetically cloned using the nucleus of a somatic cell from a fully
developed donor and an egg from which the nucleus had been
removed.23 A second was the generation of mammalian (mouse)
embryo stem (ES) cells in 1981,24 and a third was the generation of
interspecific mammalian "chimeras"-mammalian embryos and full-
term animals originating from embryo cell mixtures-beginning with
mice, rats and rabbits in the early 70s, and culminating in the dramatic
publication of reports of viable "geeps" (goat-sheep chimeras) in
1984.25 As we will see, not one of these technological achievements
was accomplished with the overt goal of producing modified humans
or quasi-humans. Indeed, all this work was initiated during a period
when scientific curiosity concerning the nature of genetic and
developmental processes were the motivating forces for entering this
line of work. As little as thirty years ago, molecular genetics, and
particularly developmental biology, the field from which transgenic
animals, stem cells, cloning and chimeras originated, had no economic
prospects nor obvious medical potential. Moreover, despite enormous
technical advances in the ability to analyze and real, but more modest,
progress in the ability to manipulate gene expression in embryos,
theoretical understanding of the relationships between genes and traits
26during development remains primitive. Nonetheless, in the context of
23. Ian Wilmut, et al., Viable Offspring Derived From Fetal and Adult
Mammalian Cells, NATURE, Jan. 2, 1997, at 810.
24. See G. R. Martin, Isolation of a Pluripotent Cell Line From Early Mouse
Embryos Cultured in Medium Conditioned by Teratocarcinoma Stem Cells, 78
PROC. NATL. ACAD. Sci. U.S.A. 7634 (1981).
25. See Carole B. Fehilly, et al., Interspecific Chimaerism Between Sheep and
Goat, NATURE, Jan. 5. 1984, at 634; see also, Sabine Meinecke-Tillman & B.
Meinecke, Experimental Chimaeras - Removal of Reproductive Barrier Between
Sheep and Goat, NATURE, Jan. 5, 1984, at 637.
26. For deficiencies in the existing paradigm see EVELYN F. KELLER, MAKING
SENSE OF LIFE: EXPLAINING BIOLOGICAL DEVELOPMENT WITH MODELS,
(Footnote continued...)
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externally driven changes in the organization of, and expectations
from, biological research during the same period, these experimental
techniques are now all components of the emerging deconstructive
program in human biology.
III. RAMPING UP TO THE CLONE AGE: SOCIOPOLITICAL
ASPECTS
A sea change in the socioeconomic and political environment in
which scientific research is conducted accompanied the technological
advances described above. As we have seen, developmental biologists,
particularly in the United States,27 currently face societal expectations
that the results of their experimental work are presumed applicable to
the remaking of human biology. These expectations extend well
beyond therapies for existing patients and now include calls for the
modification of new individuals from the point of conception.28
The social reorganization of biological research occurred in the
general post-World War II context of increased government attention• • 29
to, and funding of, science and engineering. Many of those broader
METAPHORS AND MACHINES (Harvard University Press 2002) and Stuart A.
Newman, Developmental Mechanisms: Putting Genes in their Place, 27 J. BIosci.
97, (2002). For alternative approaches see Stuart A. Newman & Wayne D.
Comper, 'Generic' Physical Mechanisms of Morphogenesis and Pattern Formation,
110 DEV. 1 (1990), Scott F. Gilbert & Sahotra Sarkar. (2000). Embracing
complexity: organicism for the 21st century. Dev Dyn, 219(1), 1-9, and GERD B.
MULLER & STUART A. NEWMAN (Eds.). ORIGINATION OF
ORGANISMAL FORM: BEYOND THE GENE IN DEVELOPMENTAL AND
EVOLUTIONARY BIOLOGY. (MIT Press, 2003).
27. See Annas, supra note 3. There are currently no federal statutes restricting
developmental manipulation of human embryos in the United States. Legal bans
or moratoria on cloning and certain other manipulations of human embryos have
been enacted in several European nations, Japan, Israel and Australia, among
others.
28. See sources cited supra note 7.
29. See Vannevar Bush and R.C. Atkinson, Science - The Endless Frontier: A
Report to the President on a Program for Postwar Scientific Research (National
Science Foundation 1980) (1945). See also S.W. Leslie, The Cold War and
American Science: The Military -Industrial - Academic Complex at MIT and
Stanford (Columbia University Press 1993); and J. Wang, American Science in an
Age of Anxiety: Scientists, Anticommunism and the Cold War (University of
North Carolina Press 1999).
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changes spawned by the expanded public economies of the New Deal
and its European counterparts, however, were tailored to the physical
sciences in their critical roles in large-scale industrial and military
development.3" The modern biology of gene and embryo manipulation,
in contrast, came of age in the Reagan-Thatcher period of aggressive
private appropriation of the fruits of prior public spending, a climate
that still prevails.
Three key changes in the socio-legal and political environment
beginning in 1980 profoundly altered the culture of biological research
in the United States:
(i) The passage of the Bayh-Dole Act" by the U.S. Congress: This
occurred in response to industry's reluctance to invest in new
technologies that had been developed in universities using federal
funding.32 Since the patent rights to these technologies traditionally
and legally resided with the government on behalf of the public,
companies could rarely obtain exclusive licenses.3  The Bayh-Dole Act
was predicated on the theory that the public would eventually benefit
if patent rights to inventions paid for by federal grants were assigned to
the grantees (universities and their investigator-employees), who
would in turn be freed to seek venture capital and exclusive corporate
licensees. 4 With the resulting financial incentives, the engines of
creativity and commerce would be fired up, it was held, and all would
gain.
The Bayh-Dole Act indeed initiated an era of academic
entrepreneurship and reoriented the attention of major universities on
their intellectual property portfolios and financial bottom lines.35
Although it was not directed in any specific way at the biological
sciences and was meant to encompass all federally funded science and
engineering-based technologies, the coincidence of the enactment of
this legislation with the DNA revolution of the 1980s and 1990s
impressed a commercial stamp on much of the new biology. In
30. See LESLIE, supra note 29. See also, WANG, supra note 29.
31. See Government Patent Policy Act of 1980, Pub. L. No. 96-517, 94 Stat.
3019.
32. See The Bayh-Dole Act: A Guide to the Law and Implementing
Regulations (1999), at www.ucop.edu/ott/bayh.html (last visited May 19, 2003).
33. Id.
34. Id.
35. Eyal Press and Jennifer Washburn, The Kept University, THE ATLANTIC
MONTHLY ONLINE, March 2000, at
http://www.theatlantic.com/issues/2000/03/press.htm.
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particular, informal scientific give-and-take that had characterized
biological research in earlier periods was curtailed 6 and conflict of
interest concerns that were previously unknown to fields such as cell
and developmental biology became prominent.37 Whether or not the
public has actually benefited in any net fashion from this new scientific
culture is unclear." Importantly for the issues discussed here, the
biotechnology industry set in motion by the privatization of biological
science, and its representative organizations, have been major driving
forces behind acclimatizing the public to instrumental uses and
commercialization of genetically modified human embryos.39
(ii) The Supreme Court's decision in Diamond v. Chakrabarty: 4This
case opened the way to the patenting of living organisms and, although
it did not address itself specifically to these issues, contributed to a
climate of acceptance of privatization of naturally occurring cell types
and DNA sequences. Although the United States Patent and
Trademark Office (PTO) opposed the granting of a patent to Dr.
Ananda M. Chakrabarty and his employer, the General Electric
Corporation, for an oil-eating bacterium, 41 it was overruled by the
Court of Customs and Patent Appeals. That court held, absurdly, that
bacteria are "more akin to inanimate chemical compositions... [than] to
36. Id.
37. See generally Sheldon Krimsky, Biotechnics & Society: The Rise of
Industrial Genetics (Praeger 1991).
38. The development of digital computers, and of monoclonal antibodies,
which have become essential biomedical research tools, progressed rapidly despite
lack of patent protection of key early technological advances. See JOHN
PALFREMAN & DORON SWADE, THE DREAM MACHINE: EXPLORING THE
COMPUTER AGE (BBC Books,1991) 106, 183 ; see also ALBERTO CAMBROSIO &
PETER KEATING, ExQuIsITE SPECIFICITY: THE MONOCLONAL ANTIBODY
REVOLUTION forward (Oxford University Press 1995). In fact, it has been
suggested that biotechnology patents can actually impede scientific progress and
technological innovations. See Michael A. Heller & Rebecca S. Eisenberg, Can
Patents Deter Innovation? The Anticommons in Biomedical Research, 280 SCIENCE
698, 698-699 (1998).
39. See, e.g., the June 2001 testimony of Thomas Okarma, President of Geron
Corporation, on behalf of the Biotechnology Industry Organization, before the
Committee on Energy and Commerce of the U.S. House of Representatives, at
http:
//energycommerce.house.gov/107/hearings/06202001Hearing291/Okarma450.htm.
40. 447 U.S. 303 (1980).
41. Id. at 303-309.
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horses and honeybees and raspberries and roses.",12 Notwithstanding
the stated distinction, the Supreme Court's upholding of this decision
in Chakrabarty enabled the issuance of patents on mice, pigs and cows,
some containing introduced human genes,43 as well as naturally
occurring human cells44 and nonhuman mammals containing such
cells.45 In April 1987, the U.S. Patent Commissioner issued a rule
stating that "[t]he PTO now considers nonnaturally occurring,
nonhuman, multicellular living organisms, including animals, to be
patentable subject matter. ''46 A year later, the PTO granted the first
patent for a mammal and its progeny to Harvard University.47 The
new "composition of matter" was the Oncomouse-a strain of
genetically modified mice that developed cancer at a rate of 40-fold
that of the unmodified strain.48
(iii) The election of Ronald Reagan: This President's agenda
included the rollback of the right to abortion affirmed by the Supreme
Court in its 1972 decision in Roe v. Wade.49 From the 1950s, when the
chemical nature of the genetic material as DNA had first been
delineated, through 1980, a major utility of identifying sequence
aberrations in disease-related genes was acknowledged to be in the
potential afforded to inform decisions about elective termination. This
potential was not fully realized until DNA mapping and sequencing
methods were developed in the 1970s. ° But changes in personnel in
42. In re Bergy, Coats, and Malik, 195 USPQ 344, 350 (1977); affd sub nom.
Diamond v. Chakrabarty, 447 U.S. 303 (1980).
43. See U.S. Patent No. 6,030,833, Transgenic swine and swine cells having
human HLA genes (issued Feb. 29, 2000).
44. See U.S. Patent No. 5,972,703, Bone precursor cells: compositions and
methods (issued Oct. 26, 1999).
45. U.S. Patent No. 6,353,150, Chimeric mammals with human hematopoietic
cells (issued Mar. 5, 2002).
46. Notice by the Patent and Trademark Office, Patent and Trademark office
Notice: Animals-Patentability, 1077 Official Gazette U.S. Pat. and Trademark Off.
8 (Apr. 21, 1987).
47. U.S. Patent No. 4,736,866, Transgenic non-human mammals (issued Apr.
12, 1988).
48. See Aya Leder et al., Consequences of Widespread Deregulation of the C-
MYC Gene in Transgenic Mice: Multiple Neoplasms and Normal Development,
45 CELL 485, (1986).
49. 410 U.S. 113 (1973).
50. D.M. Kurmit & H. Hoehn, Prenatal Diagnosis of Human Genome
Variation, 13 ANN. REV. GENET. 235 (1979).
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federal agencies involved in policy making and funding of the
biomedical sciences, most particularly the National Institutes of Health
(NIH), shifted the discourse on acceptable rationales for genetic
research away from prenatal diagnosis and selection, toward eventual
intervention-genetic modification and the like." The effect of this in
making developmental manipulation "politically correct" has been
largely overlooked, but it has left a permanent mark on the culture and
ideology of biological research.
These late 20th century changes in the biomedical research
environment occurred in parallel with a shift in the post-World War II
U.S. academic culture that brought renewed respectability to the
search for genetic explanations and remedies for human
characteristics. After the assimilation of the gene concept into the
mainstream of biological thought in the early 201h century, scientists
and other commentators across the political spectrum began to
attribute human group differences, including differences in
intelligence, moral perception and other valued qualities, to genetic
differences between the groups.12 Anti-miscegenation laws in the U.S.,
sterilization laws in the U.S. and countries such as Sweden, and
ultimately the policies that led to the Nazi death camps, were bolstered
by the eugenic writings of some of the most prestigious genetic
scientists of this country and England.53
51. President Reagan's Secretary of Health and Human Services, Margaret
Heckler, was outspokenly anti-abortion. The director of the NIH, a political
appointee, was her subordinate. Deliberations on biomedical science policy
relating to embryo and fetal research increasingly made use of opponents of
abortion as panelists and consultants (see, e.g. , Report of the human fetal tissue
transplantation panel, U.S. National Institutes of Health, December, 1988). During
this period and the Bush presidency that followed, articles by NIH officers and
favorite consultants began to appear that suggested that germ line intervention,
once technically perfected, would be a reasonable alternative to prenatal diagnosis
and selective abortion for those whose religious beliefs led them to reject the
latter. See W.F. Anderson, Prospects for Human Gene Therapy in the Born and
Unborn Patient. 29 CLIN. OBSTET. GYNECOL. 586 (1986); R.M. Cook-Deegan,
Human Gene Therapy and Congress,1 HUMAN GENE THERAPY 163 (1990); Nelson
A. Wivel & Leroy Walters, Germ-line Gene Modification and Disease Prevention:
Some Medical and Ethical Perspectives, 262 SCIENCE 533 (1993).
52. Daniel J. Kevles, In the Name of Eugenics: Gentics and the Uses of
Human Heredity, passim (Knopf 1985).
53. See J. B. S. Haldane, a Paper Read to the Heretics, Cambridge, on Feb. 4,
1923, Daedalus; or Science and the Future (E.P. Dutton & Co. 1924); R. Fisher,
The Genetical Theory of Natural Selection (Clarendon Press 1930); Hermann J.
(Footnote continued...)
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After World War II, due to revulsion from Nazi actions and in
response to an increasing acceptance of the legitimacy of calls to
redress the legacy of racism in the U.S., this mode of discourse
temporarily went into eclipse in academia.54 By the late 1960s,
however, the pursuit of biological, evolutionary, and thus genetic,
explanations for human biological differences, and for some of the
more negative aspects of human commonality, was well underway
again. Traits asserted to have a genetic basis included performance on
standardized intelligence tests, the propensity to be violent, to cheat on
one's mate, to become addicted to alcohol and drugs and to enslave
others. Landmarks along the way to the re-legitimization of genetic
accounts of human behavior and inclinations include Robert Ardrey's
Territorial Imperative (1966),"5 Desmond Morris's The Naked Ape
(1967)56 and Arthur Jensen's 1969 article, "How Much Can We Boost
IQ and Scholastic Achievement? 5 7 However, none of these had the
impact among biological scientists and the intellectual culture as a
whole as did the 1975 publication of Sociobiology by the Harvard
evolutionary biologist, Edward 0. Wilson.58
Although Wilson's research focused on ant societies, and many of
his examples were drawn from this area, his last chapter on the
purported genetic bases of aspects of human culture and behavior
struck a chord that continues to resonate among many academics and
other writers. 9 However, it is one thing to suggest, as Wilson did, that
Muller, Out of the Night: A Biologist's View of the Future (Vanguard Press 1935).
These three scientists were among the most important geneticists of the 2 0 1h
century. Haldane (British) and Muller (American) were identified with the
Marxist Left, Fisher (British) with the Christian Right.
54. D.B. Paul & H. G. Spencer, The Hidden Science of Eugenics, NATURE,
March 23, 1995, at 302.
55. Robert Ardrey, The territorial imperative; a personal inquiry into the
animal origins of property and nations (Atheneum 1966).
56. Desmond Morris, The naked ape; a zoologist's study of the human animal
(McGraw-Hill 1967).
57. Arthur Jensen, How Much Can We Boost IQ and Scholastic Achievement?
39 HARVARD EDUCATIONAL REVIEW 1 (1969).
58. Edward 0. Wilson, Sociobiology: the new synthesis (Belknap Press 1975).
59. See Richard J. Hernstein & Charles A. Murray, The bell curve: intelligence
and class structure in American life (Free Press, 1994). The field known as
"evolutionary psychology" also stems from sociobiology. See also Robert Wright,
The moral animal: evolutionary psychology and everyday life (Vintage Books
1995). See David Buss Evolutionary psychology: the new science of the mind
(Footnote continued...)
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one or another trait was molded by natural selection. This may be
disputable in any given case,60 but it is not scientifically naive. It is
quite another thing, however, to assert that such gene-trait
relationships are modular and transferable across genetic backgrounds.
Recent writers advocating the use of genetic technologies to acquire
biologically improved offspring, however, convey little uncertainty that
desirable human qualities will eventually be susceptible to being
engineered into an arbitrary genetic setting (i.e., a couple's own
fertilized egg) by plugging in a new gene or two.
6 1
IV. BLURRING THE BOUNDARY: CURRENT ACTIVITIES IN
HUMAN DEVELOPMENTAL BIOLOGY
As a result of the scientific achievements and socio-political
developments outlined above, and notwithstanding the enduringly
enigmatic nature of the developmental process, by the 1990s a
significant segment of the public in the U.S. were ready to contemplate
intervening in the development of their offspring. At the present time,
four distinct, but partially related, technologies have come to be
applied, or seriously proposed to be applied, to human biology. These
are cloning, stem cell research, embryo gene modification and
chimerism.
This paper does not intend to lump these methodologies together
and to assert, for example, that all techniques that employ human
embryonic cells or tissues are morally or ethically questionable. The
production of stem cells from stored "excess" embryos in IVF clinics,
while of deep concern to those for whom the embryo has the same
moral status as full-term humans, can plainly be conducted without
reconfiguring the material nature of the human organism. This paper
will focus, rather, on the potential of these methodologies to effect
developmental transformation and their capacity, when employed in
particular combinations, to transgress any provisional definition of the
biologically human, regardless of the belief system that stipulates it.
(Allyn & Bacon 1999) and Stephen Pinker, The blank slate: the modern denial of
human nature (Viking 2002).
60. See generally examples and discussion in MICHAEL RUSE, SOCIOBIOLOGY,
SENSE OR NONSENSE? (D. Reidel Pub. Co 1979); Richard C. Lewontin, THE TRIPLE
HELIX: GENE, ORGANISM, AND ENVIRONMENT (Harvard University Press 2000); and
ULLICA SEGERSTRALE, DEFENDERS OF THE TRUTH: THE BATTLE FOR SCIENCE IN
THE SOCIOBIOLOGY DEBATE AND BEYOND (Oxford University Press 2000).
61. See generally sources cited supra note 7.
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(i) Cloning-The cloning of a sheep by a Scottish agricultural
research group, reported in February 1997,62 provoked a spectrum of
responses from philosophers, ethicists and other observers of science.
Opinions ranged from the assertion that cloning technologies should
never be applied to humans, to enthusiasm for the prospects of doing
just that.63 In interviews, and in testimony before the U.S. Senate, Ian
Wilmut, the leader of the scientific group that accomplished the
cloning feat, expressed his hope that no one would attempt to clone a
human. ' Although the patents that he and his colleagues were
awarded specifically covered human cloning, Wilmut stated that this
provision was intended to foreclose others from attempting it.65 Two
years later, after the report of the generation of ES cells from human
embryos (see infra), Roslin Bio-Med, the company Wilmut and his
colleagues formed to exploit the cloning technique for animal
breeding, merged with Geron, Inc., a U.S. company with patent rights
on the ES cell technology. The stated business model of the new
company was to generate ES cells of defined genetic constitution from
clonal human embryos. 6
Cloning to produce full-term human individuals currently has little
support in the United States or in other countries. One reason is the
accumulation of data from scientific studies during the five years
following the announcement of the first mammalian clone showing
that the procedure is highly hazardous. Clonal mice, for example,
exhibit perturbed patterns of expression in hundreds of genes,67 and
62. Wilmut, supra note 23.
63. For early reactions, see, e.g., citations in Stuart A. Newman, Human
Cloning and the Law, 1 J. BIOLAW AND BUSINESS 59 (1998). For additional views,
see also GREGORY E. PENCE, FLESH OF MY FLESH: THE ETHICS OF CLONING
HUMANS: A READER (Rowman & Littlefield 1998), and MARTHA NUSSBAUM &
CASS SUNSTEIN, CLONES AND CLONES: FACTS AND FANTASIES ABOUT HUMAN
CLONING (Norton 1998).
64. Statement before the Subcommittee on Public Health and Safety of the
Senate Committee on Labor and Human Resources, Mar. 12, 1997, at
http://www.cnn.com/HEALTH/9703/12/nfm/cloning/index.html.
65. American Association for the Advancement of Science, Forum on Cloning,
available at http://www.aaas.org/spp/sfrl/projects/cloning.htm (June 25, 1997)
(discussing comments made by Ian Wilmut).
66. M. Wadman, US Stem-Cell Pioneers Buy 'Dolly' Cloning Company,
NATURE, May 6, 1999, at 92.
67. David Humpherys et al., Epigenetic instability in ES Cells and Cloned
Mice, 293 SCIENCE 95, 95 (2001); David Humpherys et al., Abnormal Gene
(Footnote continued...)
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cloned animals of all species in which it has been attempted have high
rates of unexplained postnatal deaths, as well as anomalies such as
enlarged hearts and grossly abnormal lungs and signs of premature
agingi8 It stands to reason that a technique that brings together the
remnants of two damaged cells, an egg from which the nucleus has
been removed and the extirpated nucleus of a somatic cell, will have
difficulty cooperating to produce a presentable member of the
originating species. Moreover, whereas many biological processes are
protected by error-correcting mechanisms that have evolved over vast
periods of time (for example, errors in the replication of DNA are
repaired by numerous sophisticated enzyme systems), evolution has
not confronted, nor arrived at correctives for, the errors introduced
into the developmental process resulting from this atypical
combination of cell parts.
On the other hand, the prospect of full-term human cloning was
enthusiastically received by some opinion makers, including a U.S.
Senator 9 and the chief technology officer of Microsoft, when Dolly the
sheep was first announced.70 More recently, a specialist in bioethics
and the law has opined that the Supreme Court has grounds to affirm
the right to clone oneself.7" Claims by Clonaid, an affiliate of the
Raelian religious cult, that they had produced several full-term human
clones were met with skepticism and condemnation by the mainstream
72
media, but the pioneering spirit of "early adopters" of such
technologies has also been praised in some recent books.73 If a few
Expression in Cloned Mice Derived from Embryonic Stem Cell and Cumulus Cell
Nuclei, 99 PROC. NATL. ACAD. SCI. U.S.A., 12889, 12889 (2002).
68. John F. Allen & Carol A. Allen, A Mitochondrial Model for Premature
Aging of Somatically Cloned Mammals, 48 IUBMB LIFE, 369, 369 (1999). See also
P. Chavatte-Palmer et al., Cloning and Associated Physiopathology of Gestation,
28 GYNECOL. OBSTET. FERTIL. 633 (2000); Rudolf Jaenisch & Ian Wilmut,
Developmental Biology: Don't Clone Humans! 291 SCIENCE 2552 (2001).
69. Jeff Levine, Scientist Who Cloned Sheep: Cloning Humans Would Be
'Inhuman,' March 12, 1997, at
http://www.cnn.com/HEALTH19703/12/nfm/cloning/index.html.
70. Nathan Myhrvold, Human Clones: Why Not?, SLATE, March 13, 1997.
71. Rick Weiss, Legal Barriers to Human Cloning May Not Hold Up, WASH.
POST. May 23, 2001, at A01.
72. D. Grady & R. Pear, Claim of Human Cloning Provokes Harsh Criticism,
N.Y. TIMES, Dec. 29, 2002 at A18; G. Kolata, & K. Chang, For Clonaid, a Trail of
Unproven Claims, N.Y.TIMES,(Jan. 1, 2003), at A13; Gerald Schatten et al.,
Cloning Claim is Science Fiction, Not Science, 299 SCIENCE 344 (2003).
73. See SILVER; and STOCK. supra note 7.
20031
Journal of Contemporary Health Law and Policy
confirmed human clones relatively free of obvious health problems
were to be presented, it is reasonable to expect that opposition to
cloning would diminish, despite the biological uncertainties. These
uncertainties include the complete lack of knowledge of how the gene
disregulation that seems inevitably to accompany cloning would affect
the "wiring" of the human brain that occurs during development.74
The motivations for producing full-term clones from a known
prototype have been widely discussed 5  Common experience with
natural human clones-identical twins, triplets, etc.-show that
biologically related traits such as personality, tastes and the occurrence
of diseases, such as diabetes and cancer, are not fully determined by
one's genes. Most people now understand that producing genetically
identical organisms, as effected by cloning, is not the same thing as
producing organisms that are identical in every important respect.
This has quelled some of the impulse toward full-term cloning, but not
all of it. As we will see, the merging of cloning with stem cell research
and germline manipulation is creating even greater incentives to
produce full-term, or near full-term clones.
(ii) Embryo stem (ES) cells-Embryo stem cells entered the world in
1981 and have since become a source of promised health benefits,
secular-religious controversy, political realignments and new business
models. Gail Martin, a researcher at the University of California, San
Francisco, found that cells isolated from early mouse embryos (at a
stage corresponding to about a week of human gestation) could, if
exposed to appropriate growth factors76 and a "feeder layer,
77
continue to divide in culture.78 Like certain cancer cells, ES cells would
give rise to a variety of differentiated cell types if removed from the
feeder layer. ES cells have the potential to form neuron-like cells,
cartilage, cells resembling the endodermal lining of the gut and so
74. Known developmental disorders of the brain are associated with
widespread gene dysregulation in brain tissue; see e.g., M. Freidl et al.,
Deterioration of the Transcriptional, Splicing and Elongation Machinery in Brain of
Fetal Down Syndrome, 61 J. NEURAL. TRANSM. SUPPL. 47 (2001). It is reasonable
to expect that the global gene dysregulation induced by cloning (see supra, note
67) would be associated with defects in the wiring of the neural circuits of the
brain, although direct evidence is not available.
75. See generally Newman; PENCE; and NUSSBAUM & SUNSTEIN, supra note 63.
76. Le., nutritive and stimulatory molecules different from those these cells
normally encounter.
77. Le., a population of nonembryonic cells.
78. Martin, supra note 24.
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forth. These cells continue to reproduce themselves as a tumorigenic
stem cell population, as demonstrated by their propensity to form
carcinomas when injected subcutaneously into adult mice.79  The
potential of these cells to generate any cell of the juvenile or adult
body was demonstrated by the ability of an ES cell to contribute to all
tissues and organs of a developing embryo into which it had been
incorporated at an early stage.Y° It did so without inducing any tumors
in the resulting individual- in effect, the microenvironment provided
by the normal embryo could "tame" this abnormal cell type.81
Between the time that Martin described mouse ES cells in 1981 and
when James Thomson, a reproductive biologist at the University of
Wisconsin, described human ES cells in 1998,82 there had been little
discussion of the reparative potential of ES cells. First, human cancer
cells ("teratocarcinomas") with properties similar to ES cells had been
available for more than thirty years83 and no plausible therapeutic
modalities had emerged from the numerous studies devoted to them.
Second, even in the mouse system itself, where both authentic ES cells
and virtually unlimited genetically compatible subjects had been
available since 1981, there had been essentially no progress in curing or
even palliating diseases or disabling conditions for which mouse
"models" existed, such as diabetes, spinal cord injury, Parkinsonism
and so forth.84
However, the intervening seventeen years had been precisely the
period in which the Bayh-Dole act and the Chakrabarty decision had
impressed their stamp on biomedical science. A comparison of the last
79. Id.
80. See Sakura Saburi et al., Developmental Fate of Single Embryonic Stem
Cells Microinjected Into 8-cell-stage Mouse Embryos, 62 DIFFERENTIATION 1
(1997).
81. Id.
82. James A. Thomson, et al., Embryonic Stem Cell Lines Derived From
Human Blastocysts, 282 SCIENCE 1145-7 (1998).
83. See Virginia E. Papaioannou, Ontogeny, Pathology, Oncology, 37. INT. J.
DEV. BIOL. 33, 33-37 (1993). Although any single cell line derived from a
teratocarcinoma is not as versatile as an ES cell no individual candidate for
reparative therapy requires a fully totipotent cell population.
84. See, e.g., Huda Y. Zoghbi & Juan Botas, Mouse and Fly Models of
Neurodegeneration, 18 TRENDS GENET, 463, 463-471 (2002); F. Susan Wong &
Charles A. Janeway, Jr., Insulin-Dependent Diabetes Mellitus and its Animal
Models. 11 CURR OPIN IMMUNOL 643, 643-647 (1999); See also, Michael S. Beattie,
et al., Cell Death in Models of Spinal Cord Injury. 137 PROG BRAIN RES. 37 (2002).
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sentences of the summary paragraphs in the papers of Martin,
Thomson and coworkers is revealing. Martin's seems almost quaint
now in its pure science orientation: "The availability of such cell lines
should make possible new approaches to the study of early mammalian
development. '" 85 The corresponding sentence in the Thomson paper
had a more 1990s flavor: "These cell lines should be useful in human
developmental biology, drug discovery, and transplantation
medicine." 86 CNN's web report of the announcement ran with the
headline: "Researchers isolate human stem cells in the lab:
Breakthrough could lead to treatments for paralysis, diabetes." 87
As of mid-2003, there remain few studies using the mouse as an
experimental system that point to therapeutic efficacy for ES cells.
Mouse ES cells or "pluripotent" subpopulations derived from them
can sometimes repopulate damaged tissues in mice, but they usually
also give rise to malignant tumors as well.88 Human ES cells, when
injected into immunocompromised mice incapable of rejecting them,
usually form benign tumors in addition to various differentiated cells.8 9
It is not clear whether human ES cells grafted into human patients
would behave as they do in mice, or rather behave like mouse ES cells
grafted into mice, forming malignant tumors.
A different kind of stem cell, the so-called embryo germ (EG) cell, is
prepared by growing tissue isolated from five-to-nine-week fetuses
rather than very early stage embryos.9° These cells have the advantage
of not forming tumors when injected into immunocompromised mice.91
However, it is not clear how they would behave in human patients.
EG cells appear to be capable of generating the full spectrum of cell
85. Martin, supra note 24, at 7634.
86. Thomson et al., supra note 82, at 1145.
87. See Researchers Isolate Human Stem Cells in the Lab, CNN.coM, Nov. 5,
1998, at http://www.cnn.com/HEALTH9811/05/stem.cell.discovery/index.html.
88. See Martin, supra note 24.
89. Benjamin E. Reubinoff, et al., Embryonic Stem Cell Lines From Human
Blastocysts: Somatic Differentiation In Vitro, 18 NATURE BIOTECHNOLOGY 399,
399 (2000).
90. Michael J. Shamblott, et al., Derivation of Pluripotent Stem Cells From
Cultured Human Primordial Germ Cells, 95 PROC. NATL. ACAD. Sci. U.S.A.,
13726, 13726 (1998).
91. Michael J. Shamblott, et al., Human Embryonic Germ Cell Derivatives
Express a Broad Range of Developmentally Distinct Markers and Proliferate
Extensively In Vitro. 98 PROC. NATL. ACAD. Sci. U.S.A. 113, 113 (2001).
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and tissue types seen with ES cells92 and, therefore, would have equal
therapeutic potential.
As noted, the reparative and tumor-forming potential of both mouse
and human stem cells can be tested in immunocompromised mice. For
human testing, or therapy, the transplanted cells would in most cases
be rejected by the human host since they are of a different genotype
and would provoke an immune reaction that could destroy the graft, or
worse, prove fatal to the patient. The human ES cell lines that existed
as of the summer of 2001, and were approved for further study using
federal funds by President George W. Bush,93 would, in general, not be
immunologically tolerated by an arbitrary patient.
It is for this reason that proposals have been made and have been
strongly advocated by the spinal cord-injured actor and activist
Christopher Reeve, 94  among other patient and industry
representatives,95 to permit federal funding of the production of clonal
embryos-embryos made by nuclear transfer that would have the same
genotype as the patient-and to resist any legal restriction on these
embryos being produced with private funds.96 This prospect, termed
"therapeutic" cloning, although "experimental" cloning is a more
accurate term for it, has gained the support of pro-choice legislators
across party lines, in both houses of Congress97 and even some
opponents of abortion such as Senator Orrin Hatch, who has
reformulated his opposition to abortion as only pertaining to embryos
that have been implanted in a woman's uterus, and which the woman
92. Id.
93. President George W. Bush, Remarks by the President on Stem Cell
Research (Aug. 9, 2001) (transcript available at
www.whitehouse.gov/news/releases/2001/08/20010809-2.html).
94. Christopher Reeve, Statement on Cloning Debate, available at
http://www.genemediaorg (last visited April 11, 2003).
95. See supra note 39.
96. See President Bush's remarks, supra note 93. Current administrative policy
pertains to research done with federal funds. The various pending Congressional
bills call for legal bans on all forms of cloning or only full-term ("reproductive")
cloning. Any research not banned by Congress but subject to an Administrative
funding restriction could still be supported from private sources.
97. S. 2439, 107th Cong. (2002). This bill, introduced by Sens. Arlen Specter
(R-PA), Edward Kennedy (D-MA) and Dianne Feinstein (D-CA), had the
intention of permitting experimental cloning, as did a substitute amendment to a
more restrictive bill (H.R. 2505) introduced in the House of Representatives the
previous year. (See H.R. 2505, 107th Cong. (2001)).
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seeks to eliminate. 9' The drive to get Congress and the public to
accommodate itself to experimental cloning has occurred with little
acknowledgement that alternative strategies exist for altering existing
ES cell lines so as to prevent their immune-mediated rejection."
Some research groups are working on culture methods to extend the
viability of human embryos in vitro,1°° and this could afford the
possibility of harvesting EG cells from two-month fetuses (currently
legal, though not approved for federal funding).10 However, patient
advocacy groups, biotech industry representatives and legislators have
yet specifically to advocate the generation of clonal fetuses for the
production of EG cells genetically matched to the patient.
Such reluctance could easily give way as better products of these
technologies emerge. After Dolly the sheep was cloned, a British
researcher speculated that inactivation of brain-inducing genes could
be used to produce headless full-term human clones for organ
harvesting.' °  A second British biologist, a prominent public
spokesperson on scientific issues, opined that this proposal raised no
ethical issues. '03
(iii) Embryo gene modification-The hazards of genetic
modifications to humans are usually discussed in terms of somatic
(body cell) modification, in which only nonreproductive tissues are
98. Dawn House, Hatch Stand Stirs Debate on Cloning, SALT LAKE TRIB.,
April 30, 2002, at http://www.sltrib.com/2002/apr/04302002/utah/732910.htm). See
also Eugene Russo, Clone Hearings Continue, THE SCIENTIST, Jan. 30, 2002. This
line of argument gives credibility to the charge that, for some, opposition to
abortion is more about curtailing women's autonomy than the welfare of the
embryo.
99. See D.S. Kaufman & J.A. Thomson, Human ES Cells Haematopoiesis and
Transplantation Strategies, 200 J. ANATOMY 243 (2002); F. Fandrich et al.,
Embryonic Stem Cells Share Immune-Priviliged Features Relevant for Tolerance
Induction, 80 J. MOL. MED. 343 (2002).
100. Robin McKie, Men Redundant? Now We Don't Need Women Either.
Scientists Have Developed an Artificial Womb that Allows Embryos to Grow
Outside the Body, OBSERVER INTL, Feb. 10, 2002, available at
www.observer.co.uk/international/story/0,6903,648024,00.html.
101. See Fact Sheet, The White House, President George W. Bush, Embryonic
Stem Cell Research (Aug. 9, 2001) (available at
www.whitehouse.gov/news/releases/2001/08/print/20010809-1.html).
102. J. Slack, quoted in S. Connor & D.Cadbury, Headless Frog Opens Way for
Human Organ Factory, LONDON SUNDAY TIMES, Oct. 19, 1997, available at
www.organicconsumers.org/Patentheadless.html.
103. Id. at 2 (referring to British biologist L. Wolpert).
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affected, and germline (egg or sperm cell) modification, in which
changes to an individual's DNA can be passed down to future
generations.' °4  However, genetic modification of early embryos,
similarly to cloning, is hazardous to developing individuals even when
there is no germline transmission to future generations.
The hazards of germline transmission of DNA modification are
clear. For example, "germline introduction in mice of an improperly
regulated normal gene resulted in progeny with unaffected
development, but high tumor incidence during adult life."'' 5  Such
effects may not be recognizable for a generation or more.
It is important to recognize, however, that the hazards to the embryo
of such alterations are not eliminated even if there is no germline
transmission. The biology of the developing individual will still be
profoundly altered by the manipulation of his, or her, genes at an early
stage, hence the utility of the concept of "developmental
manipulation" to cover both cloning and germline procedures.
Laboratory experience shows that insertion of foreign DNA into
inopportune sites in an embryo's chromosomes can lead to extensive
perturbation of development. For example, the disruption of a normal
gene by insertion of foreign DNA in a mouse caused abnormal circling
behavior when present in one copy, lack of eye development, lack of
development of the semicircular canals of the inner ear and anomalies
of the olfactory epithelium (the tissue that mediates the sense of
smell), when the mice were inbred so that the mutation appeared in
the homozygous form (i.e., on both copies of the relevant
chromosome).' °6 Another such "insertional mutagenesis" event led to a
strain of mice that exhibited limb, brain and craniofacial
malformations, as well as displacement of the heart to the right side of
the chest, in the homozygous state.'0 7 Each of these developmental
anomaly syndromes were previously unknown. From current, or even
anticipated,' 8 models for the relationship between genes and
organismal forms and functions, the prediction of complex phenotypes
104. See Paul R. Billings, et al., Human Germline Gene Modification: A Dissent,
353 LANCET 1873(1999).
105. Id.
106. See Andrew J. Griffith, et al., Optic, Olfactory, and Vestibular
Dysmorphogenesis in the Homozygous Mouse Insertional Mutant Tg9257, 19 J.
CRANIOFAC. GENET. DEV. BIOL. 157 (1999).
107. See Gurparkash Singh, et al., Legless Insertional Mutation: Morphological,
Molecular, and Genetic Characterization, 5 GENES DEV. 2245, 2245 (1991).
108. See sources cited supra note 26.
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on the basis of knowledge of the gene sequence inserted or disrupted is
likely to remain elusive.
Unexpected and even fatal outcomes of attempts at somatic cell
gene modification have plagued this area of medicine.' °  However,
attempts at developmental modification would be susceptible to a
distinct category of hazard not shared by the somatic procedures. The
tissues of a developed organism are in some sense modular-if blood,
skin, a heart or a liver is diseased or damaged, it can be replaced by a
substitute without changing the "nature" of the individual. Similarly,
with gene alteration in a developed individual, in reasonable candidate
cases for somatic therapy, the gene is playing a defined role in a
particular tissue or organ," ° and the goal of the modification is to
replace, or correct, the poorly functioning gene in one or a very limited
set of tissues. " '
During development, the situation is much more complicated.
Tissues and organs are taking form during this period and genes
function in anything but a modular fashion. In development many, if
not most, gene products can have multiple effects on the architecture
of organs and the wiring of the nervous system, including the brain."'
Individuals produced by developmental intervention (particularly as it
109. Nikunj Somia & Inder Verma, Gene therapy: Trials and Tribulations, NAT.
REV. GENET. 1, 91-99 (2000).
110. Even in cases where the gene's protein product is confined to one or a few
tissue types its function may depend in a complex and elusive fashion on other
gene products or cell properties. This has proved to be the case for the -globin
protein compromised in sickle cell disease; see A. Mozzarelli, J. Hofrichter, J., and
W.A. Eaton, Delay time of hemoglobin S polymerization prevents most cells from
sickling in vivo., 237 SCIENCE 500, 500-6 (1987); and the transmembrane
conductance regulator protein compromised in cystic fibrosis; see The Cystic
Fibrosis Genotype-Phenotype Consortium, Correlation between genotype and
phenotype in patients with cystic fibrosis, 329 N. ENGL J MED. 1308, 1308-13 (1993).
This can affect the success of somatic gene replacement or repair, and therefore
the health of the patient. The inherent identity of the individual is not at issue in
such manipulations the way it is with germline modification.
111. W. French Anderson, Prospects For Human Gene Therapy, 226 SCIENCE
401, 402 (1984); Theodore Friedmann, Progress Toward Human Gene Therapy,
244 SCIENCE 1275, 1275 (1989).
112. See I. Salazar-Ciudad, et al., Mechanisms Of Pattern Formation In
Development And Evolution. 130 DEVELOPMENT 2027, 2037 (2003); G. Streidter,
Epigenesis and evolution of brains, ORIGINATION OF ORGANISMAL FORM:
BEYOND THE GENE IN DEVELOPMENTAL AND EVOLUTIONARY BIOLOGY (G. B.
Miller & S. A. Newman, eds., MIT Press 2003).
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comes to extend beyond the single gene, to chromosomes or groups of
chromosomes"') could begin to approach the status of "experimental
artifacts," in the sense that their bodies and mentalities could be quite
different from those of anyone generated by processes using the
standard starting materials generated by evolution (including IVF).
The prospect of linking the techniques of cloning and germline
modification will create incentives that could cause some desperate
parents to put aside these concerns. Some parents have already chosen
to produce a second child in order to provide bone marrow or
umbilical cord stem cells for an existing child with a treatable disease,
such as Fanconi's anemia.'4 This is an uncertain procedure. In general,
many attempts will be needed and potentially scores of embryos will
be produced and discarded, before an appropriate "match" in tissue
type is achieved, the implanted embryo is brought to term, and the
grafted tissue accepted by the patient. Even then, success is not
guaranteed." '5
In order to improve chances for success, it could be considered
logical to clone the sick child. In this case, all the embryos generated
would be a perfect match and there would be no likelihood of rejection
of tissue grafted from the second child into the first. If the original
child's condition was due to a gene variant, genetic manipulation of the
clonal embryo could be performed to ensure that the grafted tissue
(which would remain immunologically compatible) could effect the
cure. It must also be noted that even if the fetus dies prematurely in
utero, as is often the case with clonal animals,"6 it might still be
possible to harvest therapeutically useful tissues."7 The uncertainties
of the cloning process, therefore, might not be an important
disincentive in such cases.
113. Tokuyuki Shinohara, et al., Stability of Transferred Human Chromosome
Fragments in Cultured Cells and in Mice, 8 CHROMOSOME RES. 713,723 (2000).
114. Lisa Belkin, The Made-To-Order Savior. Producing a Perfect Baby Sibling.
N.Y. TIMES MAG., July 1, 2001, at 36.
115. Id.
116. Jaenisch & Wilmut, supra note 68, at 2552.
117. Transplantation of human fetal tissues has proved effective in treating
several conditions. See e.g., Timothy M. Crombleholme, et al., Transplantation of
Fetal Cells, 164 AM. J. OBSTET. GYNECOL. 218, 227 (1991); A. Bjorklund, Cell
Replacement Strategies for Neurodegenerative Disorders, 231 NOVARTIs FOUND.
SYMP.7, 16-20 (2000). See also, T. Freeman, et al., Neural Transplantation in
Parkinson's Disease, 86 ADV. NEUROL. 435 (2001).
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A recent study with genetically-impaired mice has demonstrated
that cures, or at least palliation, of an immune deficiency can be
achieved using bone marrow from their cloned, genetically-engineered
siblings. "8 As would need to be the case with any human applications
of this methodology, multiple clonal embryos were generated by first
producing ES cells from an original clone. The gene modification was
performed on the ES cells, which were then used to form viable
embryos. Thus, all three techniques discussed so far, cloning, ES cells,
and embryo gene alteration, were brought together in' this
experimental prototype for constructing a medically useful sibling for a
sick child.
(iv) Chimerism-In November of 2002, a meeting took place at the
New York Academy of Sciences to discuss the proposal, by a
Rockefeller University scientist, to inject human embryo stem cells
into mouse embryos in order to explore the developmental fate, and
therapeutic potential, of the ES cells."9 The meeting was called
because of brewing opposition among some scientists in the
developmental biology research community. One leading stem cell
researcher in attendance stated, "I am completely opposed to putting
human embryonic stem cells into any condition that will cause moral
affront,"1 20 while others suggested alternatives to making such human-
animal chimeras that could provide the same information121 Some
participants from the New York Academy meeting were excluded
from a closed session held by investigators interested in pursuing the
chimera protocol. Among those excluded was a researcher from the
National Institute of Neurological Disorders and Stroke (NINDS),
who was also chair of the National Institute of Health Stem Cell Task
Force, and who later criticized the chimera advocates for "excessive
secrecy.
' 22
As it happens, five years previously, with the help of the social critic
Jeremy Rifkin, president of the Foundation on Economic Trends in
Washington, D.C., this writer applied for a patent on chimeric embryos
and animals containing both human and nonhuman, cells. Among the
patent application's claims was precisely what was being proposed at
118. William Rideout, Correction of a Genetic Defect by Nuclear
Transplantation and Combined Cell and Gene Therapy,109 CELL 17, 23 (2002).
119. Natalie DeWitt, Biologists Divided Over Proposal to Create Human-
Mouse Embryos, NATURE, November 21, 2002, at 255.
120. Id.
121. Id.
122. Id.
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the New York Academy forum.' 3 I had no intention of producing such
creatures, nor does U.S. patent law require that an actual prototype for
an invention be supplied, only that feasibility, novelty and utility be
demonstrated.2 4  Moreover, as noted above, ever since the 1980
Chakrabarty decision, it has been legal in the United States to obtain a
patent on living organisms and their descendants. Congress has drawn
no clear line that would preclude a pre-term human embryo, if
appropriately modified, from being patented. Further, Congress has
not indicated how many human genes or cells a non-human animal
would have to contain before it could not be patented by virtue of the
Constitutional protections pertaining to members of the human
community.'5 While a decision regarding patentability of human-
animal chimeras by the PTO would not control whether it would be
legal to produce such entities, or other types of biologically
manipulated humans, Rifkin and I considered that applying for a
chimera patent would raise these issues before the public and the legal
system in a particularly dramatic fashion.26
The proposed human-animal chimera, whose production would
depend on techniques developed in the 1970s and 1980s that led to the
generation of "geeps,"'27 could contain anywhere from a minuscule
proportion to a majority of human cells. Goats and sheep, whose
embryo cells cooperate completely in forming a composite animal
having features of both originating species, have followed separate
123. U.S. PATENT AND TRADEMARK OFFICE, 1997 CHIMERIC EMBRYOS AND
ANIMALS CONTAINING HUMAN CELLS. UTILITY PATENT APPLICATION SUBMITrED.
See also David Dickson, Legal Fight Looms Over Patent Bid on Human/Animal
Chimaeras, NATURE, April 2, 1998, at 423 (1998).
124. 35 U.S.C. §§101-103 (2000).
125. See, e.g., Thomas A. Magnani, The Patentability of Human-Animal
Chimeras,14 BERKELEY TECH L. J.443 (1999); James P. Daniel, Of Mice And
'Manimal': The Patent & Trademark Office's Latest Stance Against Patent
Protection For Human-Based Inventions, 7 J. INTELL. PROP. L. 99 (1999); Mark
Jagels, Dr. Moreau Has Left the Island: Dealing with Human-Animal Patents in
the 21st Century, 23 T. JEFFERSON L. REV. 115 (2000); Linda J. Demaine & Aaron
Xavier Fellmeth, Reinventing the Double Helix: A Novel and Nonobvious
Reconceptualization of the Biotechnology Patent, 55 Stan. L. Rev. 303.
126. See Stuart A. Newman, The Human Chimera Patent Initiative, 9 MEDICAL
ETHICS NEWSLETTER (LAHEY CLINIC) 7 (2002).
127. See Wilmut, supra note 23.
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evolutionary paths for approximately seven million years. While
humans and mice diverged perhaps thirty-two million years ago, 129 and
their embryo cells would not be expected to cooperate as readily to
form a full-term animal, development would likely progress long
enough to provide important information to developmental biologists,
hence the 2002 New York Academy workshop. Humans and
chimpanzees, another pair covered by the patent application, are about
as closely related evolutionarily as goats and sheep.'3°
In order for the chimera patent application to be admissible, it had
to document utility. 3' the application anticipated the usefulness to
developmental biologists of chimeric embryos containing human cells.
In addition, it suggested that partly human embryos could be used to
test drugs and chemicals for toxicity and as sources of transplantable
tissues and organs for human patients. It is clear from such examples
(and statements by some scientists at the New York Academy
meeting) that biotechnology is capable of producing items that, while
legal and eminently useful, would be sufficiently "transgressive" to
provoke objections by increasingly broad sectors of the public.
At the time the original patent filing was announced in early 1998,
both the PTO and critics in the scientific community (including the
researcher who patented the first mammal) accused Rifkin and me of
scaremongering - speculating about monstrous quasi-human
concoctions that no responsible scientist would contemplate producing
or patenting. 1 2 Since then, however, Advanced Cell Technology, a
128. See E. Randi, et al., Allozyme Divergence and Phylogenetic Relationships
Among Capra, Ovis and Rupicapra Artyodactyla, Bovidae, 67 HEREDITY
281(1991).
129. See Chen Su & Masatoshi Nei, Evolutionary Dynamics of the T-Cell
Receptor VB Gene Family as Inferred from the Human and Mouse Genomic
Sequences, 18 MOL. BIOL. EvOL. 503 (2001).
130. Naoyuki Takahata & Yoko Satta, Evolution of the Primate Lineage
Leading to Modern Humans: Phylogenetic and Demographic Inferences from DNA
Sequences, 94 PROC. NATL. ACAD. SCI. U.S.A. 4811, passim (1997).
131. 35 U.S.C. §101 (2000).
132. See Meredith Wadman, U.S. Office Claims Right to Rule on Morality, 393
NATURE 200 (1998). Professor Philip Leder, Chair of the Genetics Department,
Harvard Medical School and developer of the Oncomouse (see supra, note 48 and
accompanying text) stated on the National Public Radio program All Things
Considered "[tihe creation of chimeras is an outlandish undertaking. No one is
trying to do it at present, certainly not involving human beings." See All Things
Considered (NPR Radio Broadcast, April 15, 1998).
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Massachusetts biotechnology company, announced its intention to
obtain a patent on a technique for creating cloned embryos produced
from human cell nuclei and cow eggs.133 And as we have seen, some
academic scientists have subsequently announced their intention to
produce human-mouse embryo chimeras.' 34
As it attempted with the Chakrabarty patent application, the PTO
rejected the chimera invention in its initial reviews, claiming, in the
first instance, that the human-nonhuman chimera was inappropriate
subject matter for a patent since it "embraces a human. 133 One major
difference between the Chakrabarty case and that of Rifkin and myself
is that the PTO no longer opposes patents on organisms as it did in the
late 1970s. Instead, it would like to draw a line between obviously
disturbing inventions of the sort we propose and other life forms for
which they have issued patents, such as human bone-marrow cells and
pigs containing human genes."'
V. FROM PERSON TO ARTIFACT
The prospect of human developmental manipulation holds out the
promise of biologically customized, and eventually "better" people, as
well as new modalities of reparative medicine. The first program,
already underway, if claims of the self-described extraterrestrially
affiliated biotechnology company, Clonaid,37 can be believed, is being
promoted as benign'38 in that it is a eugenics of individual choice rather
than state coercion. 9 Cheered on by futurologists unencumbered by
133. S. Hall, The Recycled Generation, N.Y. TIMES MAG., January 30, 2000, at
30.
134. See E. Check, Biotech Critic Tries to Sew Up Research on Chimaeras, 421
NATURE 4 (2003).
135. D. Dickson, U.S. Bid to Patent Human-Animal Hybrid Fails, 399 NATURE
626 (1999).
136. See generally sources cited supra notes 43 and 44.
137. See Clonaid's Website, at http://www.clonaid.com (last visited April 11,
2003).
138. See generally, BUCHANAN et al., supra note 7, at 196-202. See also STOCK,
supra note 7.
139. Hubbard & Newman, supra note 22.
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scientific skepticism,1' ° provided with the means by unscrupulous
technologists and physicians, ' and motivated by a consumer ideology
of the "new and improved" and the desire to gain competitive
advantage, technophilic early adopters will be tempted to subject their
future offspring to methods that are inherently uncertain and fraught
with potential error to accomplish preemptive "cures" of disease and
enhancement of appearance, intelligence and talent.
Although one refrain of the advocates of this vision is that
developmental manipulation of a child is just an extension of providing
it with social advantages such as piano lessons, 1 2 a scientifically
informed appraisal would have to conclude (to stay with the musical
motivation) that cloning, or genetic manipulation, in order to generate
talented performers is more akin to the commissioning of castrati by
18th Century kapellmeisters. But in contrast to the products of those
earlier experiments in biological improvement, whose culture and
social environment may have made .it difficult to resist being tracked
into the profession their handlers chose for them, modern day children
(and their lawyers) are likely to be less compliant.
'41An increasingly discussed scenario is that if certain goals are
actually achieved by the use of such techniques, genetically modified
offspring will become the new standard for those who can afford them.
This will lead to society eventually separating into genetic "haves" and
"have nots," like the world portrayed in the 1997 film Gattaca.44 The
experience of the field of developmental biology suggests that this is
based on much too optimistic projections concerning the likely success
of such attempts. Contrary to popular misconceptions (often abetted
by journalists and scientists of a reductionist bent 45), genes do not
140. Stock, supra note 7, at 104-111; see also the web site of the Extropy
Institute at http://www.extropy.org/about/index.html (last visited April 11, 2003).
141. BBC News report, Doctors Defiant on Cloning, March 9, 2001 available at
http://news.bbc.co.uk/l/hi/sci/tech/1209716.stm.
142. See, e.g., Arthur L. Caplan et al., What is Immoral About Eugenics? 319
BMJ 1284 (1999).
143. SILVER, supra note 7, at 4-11. See also, LESTER THUROW, CREATING
WEALTH: THE NEw RULES FOR INDIVIDUALS, COMPANIES AND NATIONS IN A
KNOWLEDGE-BASED ECONOMY 33 (Harper Collins 1999).
144. GATrACA (Sony Pictures 1997).
145. RICHARD DAWKINS, THE SELFISH GENE (2d ed., Oxford University Press
1989).
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constitute an organism's "blueprint," or "program"; the genotype
determines or prescribes the phenotype in only an approximate
sense. 146 A study that compared outcomes of behavioral tests on
inbred, genetically uniform strains of mice conducted in three different
laboratories showed systematic differences across environments that
the experimenters had designed to be the same. The researchers
concluded that effects of a given genetic alteration on behavior could
differ markedly despite uniformity of genetic background and
setting.
In another study in which mice were actually genetically modified
with the intention of inducing a changed behavioral profile, they
performed in a superior fashion on several tests of learning and148
memory, and were featured in the popular media as the "Doogie"
mouse, after a fictional child prodigy. 149 Not as widely reported was
that these mice also exhibited enhanced sensation of pain when
exposed to chronic stimuli.""
Humans are much less genetically uniform than inbred strains of
mice, and it is to be expected that many, if not most, attempts at
genetically engineering children will have unexpected adverse
outcomes. One way of controlling such uncertainties (to follow the
logic of this questionable enterprise) is to start with ES cells derived
from a clonal embryo produced from a known prototype and attempt
to correct or improve on the prototype. In that situation, however, the
ideology of enhancement would work against accepting the inevitable
experimental errors-children with brain damage and other profound
disabilities resulting from genetic engineering gone awry- motivating
parents in search of perfection to try again, with another of the
inexhaustible clonal ES cells, for a better result. In effect, the quality
control paradigm appropriate to any design-oriented technology would
set in.
146. See Stuart A. Newman, Idealist Biology, 31 PERSPECTIVES BIOL. MED 353
(1988). See also Miller, supra note 26. See also L. Moss, WHAT GENES CAN'T Do
(MIT Press 2003).
147. John Crabbe, et al., Genetics of Mouse Behavior: Interactions with
Laboratory Environment, 284 SCIENCE 1670, 1672 (1999).
148. Ya-Ping Tang et al., Genetic Enhancement of Learning and Memory in
Mice, 401 NATURE 63 (1999).
149. Michael D. Lemonick, Smart Genes?, TIME, Sept. 13, 1999, at 53.
150. Feng Wei, et al., Genetic enhancement of inflammatory pain by forebrain
NR2B over-expression, 4 NATURE NEUROSCIENCE 164 (2001).
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The products of mixing and matching fragments of cells and genes
from different sources are not organisms as the concept has been
understood till now. They straddle the categories of organism and
artifact. At the furthest extreme, few would deny that a concoction of
synthetic DNA and off-the-shelf chemical reagents that moved and
replicated like a living cell would have an ambiguous ontological status
somewhere between life and machine.' One can question the
Supreme Court's description of Chakrabarty's genetically variant
bacteria as an "invention,"'52 but it is clear that we are moving toward
an era of lifelike artifacts."' And what would be the moral and legal
status of such humanoids?
Even with the more circumscribed aim of producing tissues for
reparative medicine, human developmental manipulation can bring us
to a similar pass. The boundary between the acceptable and
unacceptable could easily drift under practical impetus. If ES cells
(derived from one-week clonal embryos) fail to live up to their
promise in the repair of spinal cord injuries, infarcted hearts, or type 1
diabetes, there will surely be calls to permit harvesting EG cells from
five-to-nine-week clonal embryos. Women could be encouraged to act
as gestational surrogates for clonal embryos derived from the DNA of
a patient. They may even be given the option of terminating the
cloned fetus if anomalies are detected prenatally (or even if they are
not). In either case, useful tissues could be harvested.'- Like the
indigent woman in the documentary film Roger and Me'55 who offered
rabbits for sale as "pets or meat," it will become increasingly difficult
to distinguish subjects from consumables.
While some advocates of producing clonal, genetically modified, or
chimeric embryos for research and therapy are comfortable with
151. See Jeronimo Cello et al., Chemical synthesis of poliovirus cDNA:
generation of infectious virus in the absence of natural template, 297 SCIENCE 1016
(2002); see also the recent report of plans by human genome mapper Craig Venter
to build a partly artificial life form, available at
http://abc.net.au/news/newsitems/s732339.htm.
152. Chakrabarty, 447 U.S. at 305.
153. See KEEKOK LEE, THE NATURAL AND THE ARTEFACrUAL (Lexington
Books 1999). See also BILL MCKIBBEN, ENOUGH. STAYING HUMAN IN AN
ENGINEERED AGE (Times Books 2003).
154. See generally sources cited supra note 118.
155. ROGER & ME (Warner Studios 1989).
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156growing the embryo for fourteen days, or only as long as it remains
microscopic,"' or up to a defined developmental stage such as
gastrulation (when the distinct tissue layers of the embryo are
established), 8 or through the first trimester, or to any point so long as
it is not implanted in a woman's uterus, 19 there does not appear to be a
scientifically or philosophically based inherently defensible stopping
point. Once embryo modification technology is underway, the
boundary of acceptability is in danger of being dictated by those with
the loudest voices or largest financial resources, or greatest profits to
reap.
VI. DRAWING A LINE
These projections suggest that in the absence of binding
restrictions-which would represent a societal agreement not to cross
certain absolute lines-the public could be induced to accommodate
itself to fabricated humans and near-humans, organisms that
previously existed only in the realm of speculative fiction.
An international consensus to ban full-term human cloning is
• 160
emerging, and some nations' legislative bodies have enacted or are
considering more comprehensive bans, including a ban on embryo
.- • 161
cloning for research and potential therapeutic applications. On the
156. COMMITTEE OF INQUIRY INTO HUMAN FERTILISATION AND EMBRYOLOGY,
HMSO, THE 1984 WARNOCK REPORT, CMDR 9314 (recommending a limit of 14
days for research with human embryos). See also 1990 Human Fertilisation and
Embryology Act of 1990, at
http://www.hmso.gov.uk/acts/acts1990/Ukpga_19900037 en_1.htm (last visited
June 3, 2003).
157. Michael Kinsley, Reason, Faith, and Stem Cells, SLATE.COM, Aug. 29, 2000,
at http://slate.msn.com/id/88862/.
158. The President's Council on Bioethics, Human Cloning and Human Dignity:
an Ethical Inquiry, at
www.bioethics.gov/reports/cloningreport/fullreport.html#paragraphl37.
159. See sources cited supra note 98.
160. G.A. Res. 56/93, U.N. GAOR, 56th Sess. (2002) (establishing an Ad Hoc
Committee, open to all Member States of the United Nations or members of
specialized agencies or of the International Atomic Energy Agency, for the
purpose of considering the elaboration of an international convention against the
reproductive cloning of human beings).
161. A House bill (H.R. 2505) banning all forms of cloning, sponsored by Rep.
Dave Weldon (R-FL) and Bart Stupak (D-MI) passed in the full House by a large
bipartisan majority in 2001 and a modified version of this bill, retaining the full
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other hand, some statements by bioethicists individually 162 and
113
organizationally, have affirmed the "right" to genetically engineer
one's offspring. The Council for Responsible Genetics (Cambridge,
MA), a public interest organization that has been scrutinizing the new
biotechnologies for more than twenty years, has proposed that all
cellular and genetic manipulations of human embryos be prohibited.
The Council argues that drawing this sharp line is the only way to
prevent the eventual production of experimentally damaged humans
and quasi-humans9
Under this proposed legal framework, there would be no
impediment to production of embryos by IVF for implantation, or
storage for future implantation. However, the developmental
manipulation of IVF embryos by genetic means, or the production of
clonal or chimeric embryos, would be prohibited. Establishing this line
would not prevent scientists from continuing research on ES cells from
nonclonal embryos, including genetically manipulating those ES cells.
It would, however, help individuals and societies to resist entering into
a series of dubious enterprises by which quasi-humans are produced
for their capacity to provide spare parts and other functional utilities.
Moreover, it would block a pathway leading to the intentional creation
of genetically "improved" humans, where those brought about without
the benefit of newest technologies, or those representing failed
experiments, would come to be increasingly disdained.
No legal framework can prevent the production of cloned and
genetically manipulated humans by those determined to do so, but it
can stigmatize such activities and guarantee that scientific "progress"
in these areas is not accepted into the mainstream technical literature
where it could enable further attempts. Notwithstanding
recommendations that society accommodate itself to technological
"inevitabilities ' in human developmental manipulation, the proposal
cloning ban (H.R. 534) passed in early 2003. Senators Sam Brownback (R-KS)
and Mary Landrieu (D-LA) have recently introduced The Human Cloning
Prohibition Act of 2003 (S. 245), essentially identical to H.R. 534. A similar bill
ended in a Senate stalemate in the 107th Congress.
162. See Weiss, supra note 71.
163. European Scholars Support Development of Germ Line Modification,
available at http://www.eurekalert.org/pub-releases/2002-12/sari-essl21302.php
(last visited April 11, 2003).
164. Council for Responsible Genetics, Statement on Embryo Research, June 6,
2001, at http://www.gene-watch.org/programs/cloning/embryo-statement.html.
165. STOCK, supra note 7.
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outlined here affirms the idea that humans must control technology
rather than be controlled, and in this case defined, by it.

